Alford, B. R. (1972) Meniere's Disease: criteria for diagnosis and evaluation of therapy for reporting results. Transactions of the American Academy of Ophthalmology and Otolaryngology, 76: 1462–4.
Angelborg, C., Klockhoff, I. and Stahle, J. (1973) Serum osmolality in patients with Meniere's disease. Acta Otolaryngology (Stockholm) 76: 450–4.
Arenberg, I. K. and Bayer, R. F. (1977) Therapeutic options in Meniere's disease. Archives of Otolaryngology, 103: 589–593.
Arenberg, I. K. and Goodfriend, T. L. (1979) Low plasma renin concentration in patients with Meniere's disease. American Journal of Otology, 1: 85–87.
Becker, B. and Middleton, W. H. (1955) Long-term administration of acetazolamide (Diamox) in the treatment of glaucoma. Archives of Ophthalmology, 54: 187–192.
Birmingham Medical Research Expeditionary Society Mountain Sickness Study Group (1981) Acetazolamide in the control of acute mountain sickness. Lancet, i: 180–183.
Birzis, L., Carter, C. H. and Maren, T. H. (1958) Effect of acetazolamide on CSF pressure and electrolytes in hydrocephalus. Neurology, 8: 522–8.
Brookes, G. B., Hodge, R. A., Booth, J. B. and Morrison, A. W. (1982) The immediate effects of acetazolamide in Meniere's disease. Journal of Laryngology and Otology, 96: 57–72.
Campbell, D. A., Jones, M., Renner, N. E. A. and Tonks, E. L. (1957) Combined action of Diamox and potassium carbonate in the treatment of glaucoma. British Journal of Ophthalmology, 41: 746–758.
Celestino, D., Cerulli, N. and Ianetti, G. (1976) Acid base equilibrium in Meniere's disease. Journal of Laryngology and Otology, 90: 263–275.
Celestino, D. and Ralli, G. (1980) Plasmatic osmolality in Meniere's disease. Journal of Laryngology and Otology, 94: 273–277.
Corvera, J. (1956) Carbonic anhydrase and the internal ear. Annals of Otology, Rhinology and Laryngology, 65(2): 351–5.
Erulkar, S. D. and Maren, T. H. (1961) Carbonic anhydrase and the inner ear. Nature, 189: 459–460.
Forwand, S. A., Landowen, M., Follansbee, J. N. and Hansen, J. E. (1968) Effect of acetazolamide on acute mountain sickness. New England Journal of Medicine, 279: 839–844.
Gibson, W. P. R., Moffat, D. A. and Ramsden, R. T. (1977) Clinical electrocochleography in the diagnosis and management of Meniere's disease. Audiology, 16: 389–401.
Greene, M. K., Kerr, A. M., Mcintosh, I. B. and Prescott, R. J. (1981) Acetazolamide in the prevention of acute mountain sickness: a double blind controlled cross-over study. British Medical Journal, 283: 811–813.
Hackett, P. H., Rennie, D. and Levine, H. D. (1976) The incidence, importance and prophylaxis of acute mountain sickness. Lancet, i: 1149–1154.
Hanley, T. and PlattS, M. M. (1956) Observations on the metabolic effects of the carbonic anhydrase inhibitor Diamox: mode and rates of recovery from the drugs action. Journal of Clinical Investigation, 35: 20–30.
Iwata, K., Iwata, R. and Fukuchi, Y. (1960) Neptazane in glaucoma. ActaMedica et Biologica, 8: 261–9.
Knapp, H. (1871) Clinical analysis of inflammatory affections of the inner ear. Archives of Ophthalmology and Otology, 2: 204–283.
Kupfer, C., Lawrence, C. and Linner, E. (1955) Long-term administration of acetazolamide (Diamox) in the treatment of glaucoma. American Journal of Ophthalmology, 40: 673–80.
Lawrence, D. R. (1973) In ‘Clinical Pharmacology’ p. 20.9, 4th edition, Churchill-Livingstone, London.
Lehmann, B., Linner, E. and Wilstrand, P. J. (1969) The pharmacokinetics of acetazolamide in relation to its use in the treatment of glaucoma and to its effects as an inhibitor of carbonic anhydrase. Advances in the Biosciences, 5: 197–217.
Maren, T. H. and Robinson, B. (1960) The pharmacology of acetazolamide as related to cerebrospinal fluid and the treatment of hydrocephalus. Bulletin of Johns Hopkins Hospital, 106: 1–24.
Maren, T. H., Mayer, E. and Wadsworth, B. C. (1954) Carbonic anhydrase inhibition. 1. The pharmacology of Diamox, 2-acetylamino-1, 3,4-thiadiazole-5-sulfonamide. Bulletin of Johns Hopkins Hospital, 95: 199–243.
Maren, T. H., Robinson, B., Palmer, R. F. and Griffith, M. E. (1961) The binding of aromatic sulfonamides to erythrocytes. Biochemical Pharmacology, 6: 21–28.
Moffat, D. A., Gibson, W. P. R., Ramsden, R. T., Morrison, A. W. and Booth, J. B. (1977) Transtympanic electrocochleography during glycerol dehydration. Acta Otolaryngologica (Stockholm), 85: 158–65.
Morrison, A. W. (1981) Meniere's disease. Journal of the Royal Society of Medicine, 74: 183–9.
Muftic, M. K. (1957) Acetazolamide in Meniere's disease. Archives of Otolaryngology, 65: 575–579.
Thomsen, J., Bech, P., Prytz, S., Vendsborg, P. and Zilstorff, K. (1979) Meniere's disease: lithium treatment: demonstration of a placebo effect in double-blind cross-over trial. Clinical Otolaryngology, 4: 119–123.
Torok, N. (1977) Old and new in Meniere's disease. Laryngoscope, 87: 1870–7.
Varga, G. V. and Ribári, O. (1958) Action of acetazolamide in Meniere's disease. Journal of Otology and Laryngology, 72: 920–25.
Varga, G. V., Miriszlai, E. and Szabo, L. Z. (1966) Experiences with acetazolamide therapy applied in our clinic to patients suffering from Meniere's disease for more than 8 years. Journal of Laryngology and Otology, 80: 250–269.
Weille, F. L. (1967) Microcirculation and fluid physiology of the inner ear correlated with Meniere's disease. Laryngoscope, 77: 2063–2076.